Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Adjusted EBITDA narrows to a range of $950 to $1,000 million (previously $925 to $1,025 million), and capital additions (net of reimbursements) remains the same with a range of $400 to $440 million.
Posted In: NE